Rethinking ovarian cancer III: the past decade and future directions

Nature reviews. Cancer 2026

View at publisher
Authors: Frances R. Balkwill, Céline M. Laumont, Nikki Burdett, Olivia Le Saux, Dale W. Garsed, Whitney R. Grither, Anke Nijhuis, María Sol Recouvreux, Ziqi Kang, Rugang Zhang, Katherine B. Chiappinelli, Jason S. Lee
+26 more Denarda Dangaj Laniti, Iain A. McNeish, Ahmed A. Ahmed, Robert Rottapel, José R. Conejo-García, K. Odunsi, Paul D.P. Pharoah, D. Zamarin, Charles A. Ishak, Christina Fotopoulou, Ronald J. Buckanovich, Intidhar Labidi-Galy, James D. Brenton, Ernst Lengyel, David P. Cook, Sophia George, Stephanie Lheureux, Ronny Drapkin, Kenneth P. Nephew, Sarah F. Adams, Shailja Pathania, Brad H. Nelson, A. Färkkilä, Katherine C. Fuh, Benjamin G. Neel, D Bowtell
DOI: 10.1038/s41568-026-00916-0
Cited by: 6
References: 268

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Cancer Mechanisms and Therapy

Publication details

Journal / source
Nature reviews. Cancer
Publisher
Springer Science and Business Media LLC
Volume
26
Issue
6
Pages
452–471
Publication date
13 April 2026
Language
EN